Researcher’s Profile

Jai Radhakrishnan, MD

Americas Top Doctor : 
1
1
Clinical Chief, Nephrology Division
Overview: 

Glomerular disease esp. lupus nephritis. Chronic kidney disease.

Publications: 
Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB. (2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. . Kidney Int. 77(2):152-160
Mohan S, Radhakrishnan J (2011) Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy. Clin Nephrol 75(3):233-41
Boyden LM, Choi M, Choate KA, et al (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482(7383):98-102
Labban B, Arora N, Restaino R, Markowitz G, Valeri A , Radhakrishnan J (2010) The Role of Kidney Biopsy in Heart Transplant Candidates With Kidney Disease Transplantation 89(7):887-893
Radhakrishnan J, Uppot RN, Colvin RB (2010) Case records of the Massachusetts General Hospital. Case 5-2010. A 51-year-old man with HIV infection, proteinuria, and edema N Engl J Med ;362(7):636-46
About: 

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease (including glomerular diseases and lupus kidney disease) and intensive care nephrology.

He is a fellow of the American Society of Nephrology and National Kidney Foundation. His commitment to medical education and patient care is exemplified by his numerous teaching awards and his inclusion in the Who's Who among America's Teachers & Educators, America's Best Doctors and Castle Connolly's Top Doctor.